Type 2 Diabetes
Conditions
Brief summary
CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.
Interventions
OTHERdata collection
Data collection on diabetes therapy and follow-up
Sponsors
Federico II University
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≥ 18 years; * Diagnosis of type 2 diabetes mellitus (T2DM); * Stable clinical conditions * Outpatient settings * Ability to understand the study procedures and provide written informed consent.
Exclusion criteria
* Patients with type 1 diabetes mellitus; * Active participation in interventional studies; * Any condition that may put the patient at risk by participating in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diabetes treatment adherence according to the most recent European Guidelines | 12-24-36-48 months | Outpatients clinic treatment adherence will be measured as the percentage of patients receiving guideline-directed medical therapy prescriptions. |
Countries
Italy
Contacts
CONTACTPasquale Perrone Filardi
Outcome results
None listed